HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $426,809 | +0.9% | 11,173 | -4.7% | 0.01% | +18.2% |
| Q2 2023 | $423,101 | -10.0% | 11,730 | -4.7% | 0.01% | -15.4% |
| Q1 2023 | $470,272 | -33.5% | 12,314 | -0.9% | 0.01% | -35.0% |
| Q4 2022 | $706,983 | +42.5% | 12,425 | -0.9% | 0.02% | +33.3% |
| Q3 2022 | $496,000 | -10.0% | 12,532 | 0.0% | 0.02% | +15.4% |
| Q2 2022 | $551,000 | +9.3% | 12,532 | -0.8% | 0.01% | +30.0% |
| Q1 2022 | $504,000 | -0.6% | 12,632 | +0.2% | 0.01% | +11.1% |
| Q4 2021 | $507,000 | -2.3% | 12,609 | -1.2% | 0.01% | -18.2% |
| Q3 2021 | $519,000 | -7.2% | 12,764 | +3.8% | 0.01% | 0.0% |
| Q2 2021 | $559,000 | +12.2% | 12,300 | +3.0% | 0.01% | 0.0% |
| Q1 2021 | $498,000 | -3.1% | 11,945 | -0.8% | 0.01% | -8.3% |
| Q4 2020 | $514,000 | – | 12,045 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |